Learn how IVD developers overcome FFPE DNA multiplex PCR primer design bottlenecks like primer-dimers, Tm mismatch, and amplicon competition.
Learn key workflow considerations for FFPE RNA-seq assays, from acidic cross-link reversal and fluorometry to targeted hybridization capture.
Compare hybridization capture vs. multiplex PCR for solid tumor NGS panels based on target region size, sample DNA input, and assay objectives.
Explore hybridization capture vs. PCR hotspot testing for solid tumor gene panels. Discover key technical advantages and assay design considerations.
Learn why 300x-1000x depth in solid tumor MPS panels is critical to overcome tumor heterogeneity, low cellularity, and prevent false negatives.
Discover how formalin fixation degrades nucleic acids and explore superior tissue preservation alternatives like flash-freezing for diagnostic assays.
Discover essential criteria for designing ECS panels, focusing on clinical validity, analytical performance, and quality IVD raw materials.
Match target genetic variants to optimal molecular platforms (PCR, NGS, Sanger, MLPA, Arrays). Optimize your diagnostic assay development strategy.
Learn how hybridization-based capture and biotinylated probes isolate exonic regions in NGS WES to optimize diagnostic assay development.
Learn how methylation-specific PCR (msPCR) diagnoses PWS and AS, and discover critical IVD reagent factors for assay developers.
Learn how to structure multi-tier IVD workflows using methylation, CNV testing, and UBE3A sequencing to accurately differentiate PWS and AS.
Learn how base excision repair (BER) defects and full-gene MUTYH/APC variant landscapes guide molecular diagnostic kit design for MAP.
Discover key considerations for mtDNA assay design, from MPS platform selection and long-range PCR to enzyme choice and low heteroplasmy detection.
Learn how BRCA1/2 loss-of-function causes PARP inhibitor synthetic lethality and key requirements for developing precision companion diagnostics.
Discover how defective DNA mismatch repair drives MSI in Lynch syndrome and guides marker selection and high-fidelity enzymes in CRC kit design.
Discover why multi-gene NGS panels outperform BRCA-only tests in HBOC diagnostics and key design priorities for clinical IVD assay developers.
Learn the molecular mechanism of Factor V Leiden thrombophilia and key parameters for designing accurate IVD genotyping assays.
Learn how to build a multi-tiered Rett syndrome assay workflow combining MECP2 sequencing, CNV detection, and secondary genes for 95%+ sensitivity.
Discover why AGG interruption analysis in FMR1 carrier screening stabilizes repeat tracts and enables accurate maternal transmission risk assessment.
Master HTT CAG repeat sizing: evaluate PCR stutter peaks, GC-rich challenges, and CE resolution to optimize diagnostic assay accuracy.
Discover key RET mutational hotspots (Exons 10, 11, 16) to design high-yield, cost-effective targeted screening assays for MEN2A, MEN2B, and FMTC.
Learn how to design clinical-grade DMD CNV panels covering all 79 exons, intragenic deletions, duplications, and female carrier detection.
Learn how to configure fluorescent PCR and capillary electrophoresis for Huntington's disease kit dev, from CAG thresholds to stutter peak control.
Master SMA IVD kit development using MLPA and CE. Learn key assay design rules, raw material requirements, and critical point mutation limitations.
Explore the key technical challenges in SMA assay design, from SMN1/SMN2 sequence homology and CNV quantification to detecting point mutations.
Standard CFTR panels miss up to 51% of carriers in non-European groups. Learn how ethnic variations impact assay sensitivity and design.
Learn why host background depletion is essential for clinical mNGS diagnostics and explore key IVD raw materials for high-sensitivity library prep.
Learn how Cas12a & Cas13 function in CRISPR diagnostics and discover essential IVD raw materials required for reliable diagnostic kit development.
Learn how the 6 CFTR functional classes guide precision diagnostic panel design, improve variant coverage, and enable targeted modulator therapies.
Discover why empty cassettes and CoNS cause false-positive MRSA results, and how multi-target molecular strategies resolve diagnostic errors.
Discover how host response biomarker panels confirm active infection, overcome direct pathogen detection limits, and optimize IVD assay design.
Learn the core principles of CRISPR diagnostics, from collateral cleavage to pre-amplification and high-purity IVD raw material sourcing.
Discover how microbial cfDNA differs from genomic samples and learn key strategies for sample & library prep reagent selection in molecular IVD.
Explore key strategies to overcome host nucleic acid background in mNGS assays, improve diagnostic sensitivity, and optimize library prep workflows.
Learn how digital PCR eliminates standard curves to boost qPCR precision, and discover essential raw materials for dPCR reference standards.
Explore common technical challenges in multiplex pathogen panel development and how targeted IVD raw materials restore assay sensitivity and specificity.
Discover how clinical actionability, epidemiology, and multiplex compatibility guide AMR gene selection for pneumonia and sepsis molecular panels.
Discover key strategies to eliminate amplicon cross-contamination and false positives in high-multiplex syndromic PCR panels.
Learn key raw materials and assay requirements for direct pathogen detection in whole blood without culture to enable rapid, sensitive IVD testing.
Discover essential strategies for multiplex LRTI panel design: specimen validation, AMR target selection, quantitative cut-offs, and reagent choice.
Learn how IVD manufacturers can use semi-quantitative real-time PCR and Ct cutoffs to boost C. difficile assay clinical specificity.
Learn why broad multiplex coverage is critical in IVD reagent design to catch silent carbapenemase variants like OXA-48 and prevent false negatives.
Learn how to overcome VRE assay specificity challenges, avoid vanB gut flora false positives, and optimize NAAT reagents for accurate diagnosis.
Learn multi-target design strategies for MRSA molecular IVD assays to eliminate false positives from empty cassettes and prevent false negatives.
Learn why vanA and vanB present cross-reactivity and false-positive challenges in VRE molecular assays and how to design specific screening tests.
Guide for IVD developers on selecting 16S, ITS, and 28S hypervariable regions to optimize sensitivity and specificity in bacterial and fungal assays.
Discover why dual-target MRSA assays beat single-target SCCmec-orfX designs by preventing false positives/negatives in IVD kit development.
Discover how LAMP achieves isothermal DNA amplification and what key enzyme properties ensure rapid, high-performance IVD kit development.
Learn why dsDNA dyes require melting curve analysis in qPCR and how sequence-specific labeled probes enhance IVD assay precision and multiplexing.
Discover how dPCR delivers standard-curve-free absolute quantification vs qPCR, plus essential IVD raw material selection criteria for assay design.
Learn the core raw materials for RT-PCR viral assays, including reverse transcriptase, hot-start Taq, primers, probes, and reaction buffers.
Explore how PNA oligonucleotide analogues improve diagnostic probe design with unmatched binding affinity, single-base specificity, and enzyme resistance.
Compare intercalating dyes vs. hydrolysis probes for qPCR. Learn key trade-offs in specificity, cost, multiplexing, and workflow optimization.
Learn how synthetic base pairs isoC and isoG eliminate background noise, lower limits of detection, and boost diagnostic assay sensitivity.
Compare Molecular Beacons and TaqMan probes for real-time PCR kit design. Learn key differences in specificity, multiplexing, and enzyme needs.
Discover how uncharged PNA probes offer superior binding affinity, single-base specificity, nuclease resistance, and salt-independent binding.
Learn how synthetic isoC and isoG bases eliminate cross-hybridization, reduce background noise, and boost sensitivity in bDNA molecular assays.
Explore how Clinical Genome Sequencing (cGS) outpaces cES in diagnostic yield, structural variant detection, and coverage uniformity for assay design.
Explore technical limitations of short-read MPS in clinical assays, such as high-GC regions and repeat expansions, and key strategies to solve them.
Compare cES vs cGS for diagnostic assay development: coverage depth, CNV resolution, data size, and clinical yield trade-offs.
Learn how saliva and buccal swabs affect NGS sequencing metrics and explore key strategies to optimize extraction, QC, and library prep.
Learn how wet-lab optimizations and advanced bioinformatics overcome PCR bias and mapping errors in high-GC and repetitive genomic sequencing.
Discover why cES requires 60-100x depth vs 30x in cGS, and how capture bias and enzyme selection shape IVD library preparation workflows.
Compare saliva and buccal swabs to blood for clinical WGS. Learn key sample preparation and reagent selection strategies to optimize human DNA yields.
Only 1–2% of the human genome codes for proteins. Learn how to optimize target capture assay design for highly efficient IVD diagnostic development.
Learn how semiconductor NGS detects proton release via pH shifts and key IVD reagent formulation considerations for ultra-pure, high-fidelity assays.
Learn how reversible terminator chemistry eliminates homopolymer ambiguity in molecular diagnostics through single-base, deterministic extension.
Learn how Phred quality scores (Q10, Q20, Q30) measure NGS error rates and why >90% Q30 is the gold standard for clinical diagnostic assays.
Learn why standardizing variant nomenclature with HGVS guidelines ensures diagnostic accuracy, seamless bioinformatics, and regulatory compliance.
Discover how CNVs and gene fusions drive cancer and learn key strategies to design precise oncology IVD panels for quantitative detection.
Discover how standardized HGVS nomenclature eliminates ambiguity in molecular diagnostic reporting, bioinformatics, and IVD assay development.
Learn how the distribution of SNVs, indels, and structural variants guides target selection and platform choice in molecular diagnostic assay design.
Discover how microRNA length and structure dictate raw material selection, primer design, and chemistry in liquid biopsy oncology diagnostic assays.
Learn how bacterial and viral genomic structures guide target selection, enzyme choice, and raw material optimization in molecular IVD assays.
Learn how pseudogenes cause false positives in molecular diagnostics and discover key strategies for pseudogene-safe assay design and target selection.
Discover how human genome architecture drives target selection, primer/probe design, and cost efficiency in targeted diagnostic panels.
Learn how pseudogenes cause false assay results and explore strategies—from bioinformatic design to high-specificity IVD reagents—to ensure accuracy.
Learn how 4–10°C Tm shifts, asymmetric PCR, and exonuclease-deficient enzymes optimize homogeneous SNV genotyping by melting curve analysis.
Learn how Cq determination algorithms and PCR amplification efficiency impact qPCR assay accuracy, linearity, and diagnostic reagent optimization.
Learn how MGB-modified probes boost qPCR sensitivity and specificity by lowering background noise and stabilizing short probe designs.
Learn how hydrolysis and hybridization probes differ in mechanism, post-PCR melting analysis, and qPCR diagnostic kit development.
Compare agarose and polyacrylamide matrices for molecular diagnostics. Discover key differences in separation range, resolution, and IVD performance.
Learn how internal standards and matrix-matched calibrators work together to eliminate sample variability and PCR inhibition in quantitative assays.
Learn the essential enzyme, nucleotide (dATPaS), and primer specifications required to build high-performance SDA isothermal diagnostic kits.
Discover the essential enzyme combinations, promoter primers, and raw materials needed to design robust TMA and NASBA molecular diagnostic kits.
Learn the core enzymes for TMA & NASBA RNA kit design—RT, RNase H, and T7 RNA polymerase—and how to optimize 2-vs-3 enzyme systems for IVD assays.
Learn the causes of rain in digital PCR (dPCR) and how optimizing primer, probe, and polymerase raw materials resolves partition ambiguity.
Learn how diagnostic assay developers use dUTP and UNG to prevent PCR aerosol carryover contamination and protect clinical assay accuracy.
Learn how free Mg²⁺ concentration impacts PCR sensitivity, specificity, and fidelity, and how to optimize master mixes for diagnostic assays.
Learn essential primer design rules to eliminate primer-dimers, match Tm, and enhance sensitivity in clinical PCR diagnostic assays.
Learn how 5′→3′ exonuclease activity, A-tailing, fidelity, buffer fit, and inhibitor tolerance dictate diagnostic PCR assay performance.
Learn how MgCl2 concentration impacts diagnostic PCR assay sensitivity and specificity, compensates for EDTA/dNTPs, and optimizes reaction yield.
Explore top reagent additives like DMSO, betaine, 7-deaza-dGTP, and BSA to optimize high-GC PCR amplification for robust molecular diagnostics.
Compare physical shearing and chemical fragmentation strategies for nucleic acid sample prep in IVD assay development to optimize workflow efficiency.
Compare key enzyme raw materials for isothermal amplification (Bst, RPA, Φ29) and PCR (Taq) to optimize your IVD assay design and hardware.
Learn top strategies to reduce DNA degradation during bisulfite conversion, including pre-enrichment, protective buffers, and tolerant enzymes.
Discover how isothermal amplification (RPA) eliminates thermal cycling to simplify hardware, reduce costs, and speed up POC IVD testing.
Eliminate trace gDNA in RNA isolation for RT-qPCR assays. Discover high-purity DNase strategies, smart primer design, and workflow hygiene.
Discover key sample prep parameters—volume, concentration, elution, and recovery—that maximize analytical sensitivity and lower assay LoD.
Learn how fixatives like formalin impact nucleic acids in FFPE tissues and discover best practices for oncology diagnostic assay development.